<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00802295</url>
  </required_header>
  <id_info>
    <org_study_id>VLC-JR-0204-307-11</org_study_id>
    <nct_id>NCT00802295</nct_id>
  </id_info>
  <brief_title>Aneuploidies and Different Stimulation Protocols</brief_title>
  <official_title>Influence of Ovarian Stimulation and Embryo Aneuploidy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Valenciano de Infertilidad, IVI VALENCIA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our working hypothesis is that patients undergoing &quot;in vitro&quot; fertilization (IVF) with higher
      response to ovarian stimulation protocols recover a higher number of oocytes and, this
      elevated response could be translated into increased incidence of chromosomally abnormal
      embryos. Our objective is to develop a prospective study on healthy young donors, with a
      previous cycle with high ovarian response (&gt;20 oocytes and/or E2 levels the day of the hCG
      injection &gt;3000 pg/mL), but without developing mild or severe hyperstimulation syndrome.
      After signing a proper written consent, these donors would agree to undergo two subsequent
      stimulation cycles following two different protocols. In one cycle the stimulation pattern
      would be similar to the previous one, with elevated response and, in another cycle the amount
      of gonadotropins would be cut down in order to obtain lower ovarian response. Oocytes
      obtained in each cycle would be donated to anonymous recipients and after fertilization,
      embryo quality and chromosomal status of the resulting embryos would be evaluated.
      Preimplantation genetic diagnosis (PGD) will be performed on day-3 embryos and chromosomes
      13, 15, 16, 17, 18, 21, 22, X and Y would be analyzed by fluorescence &quot;in situ&quot; hybridization
      (FISH).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aneuploidy rate with two different stimulation protocols.</measure>
    <time_frame>three months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Normal blastocyst rate</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Aneuploidy</condition>
  <arm_group>
    <arm_group_label>standard dosis protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of standard dosis of gonadotrophins for ovarian stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of low dosis of Gonadotrophins for ovarian stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gonadotrophins</intervention_name>
    <description>Administration of standard ovarian stimulation protocol</description>
    <arm_group_label>standard dosis protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low dosis Gonadotrophin</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy women between 18 - 29

          -  with previous cycle with standard dosis of Gonadotrophin and high response to the
             treatment (&gt; 20 oocytes)

          -  No symptom of OHSS

        Exclusion Criteria:

          -  donors with 2 previous miscarriages

          -  PCO

          -  Severe Male Factor
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose Remohi, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Valencia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Valenciano de Infertilidad</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2008</study_first_submitted>
  <study_first_submitted_qc>December 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2008</study_first_posted>
  <last_update_submitted>September 17, 2009</last_update_submitted>
  <last_update_submitted_qc>September 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Jose Remohi Jimenez</name_title>
    <organization>IVI Valencia</organization>
  </responsible_party>
  <keyword>Ovarian</keyword>
  <keyword>hyperstimulation</keyword>
  <keyword>Embryo</keyword>
  <keyword>Aneuploidy</keyword>
  <keyword>Ovarian hyperstimulation and Embryo Aneuploidy Rates</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneuploidy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

